Request Appointment
300 East 66th StreetFloors 1 - 4New York, NY 10065
Overview of Dr. Abuhadra
Dr. Nour Abuhadra is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Weill Cornell Medical College in Qatar and has been in practice 1 year. She is one of 525 doctors at Memorial Sloan Kettering Cancer Center and one of 91 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 30 publications and over 250 citings.
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 2015 - 2018
Weill Cornell Medical College in QatarClass of 2015
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 2021 - 2026
OH State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Susan Papizan Dolan Fellowship in Breast Oncology (Recognition of Research Excellence) University of Texas - MD Anderson Cancer Center, 2020
- ASCO Employees Conquer Cancer Foundation Merit Award American Society of Clinical Oncology, 2020
- Research Merit Award European Society Of Medical Oncology, 2020
Publications & Presentations
PubMed
- 1 citationsPredictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer.Nour Abuhadra, Fresia Pareja, Charlie White, Yuan Chen, Hannah Wen
NPJ Breast Cancer. 2025-10-02 - Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast C...Beatriz E Adrada, Mary S Guirguis, Lei Huo, Clinton Yam, Debu Tripathy
JCO Precision Oncology. 2025-10-01 - 2 citationsPredictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.Lauren M Perry, Varadan Sevilimedu, Natalia Polidorio, Nour Abuhadra, Monica Morrow
Annals of Surgical Oncology. 2025-06-01
Journal Articles
- Impact of social media for the hematologist/oncologist.Abuhadra, N et al, Seminars in Hematology, 10/1/2017
Abstracts/Posters
- Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stag...Abuhadra, N et al, ASCO 2020, Chicago, IL. USA, 5/31/2020
- The Immunomodulatory (IM) Signature Enhances Prediction of Pathologic Complete Response (pCR) to Neoadjuvant Therapy (NAT) in Triple Negative Breast Cancers (TNBC) wit...Abuhadra, N et al, ESMO Breast Conference (Oral Presentation), Madrid, Spain (Virtual due to COVID-19), 5/1/2020
- Serial TILs: Evaluating the role of mid-treatment tumor infiltrating lymphocytes (TIL) in predicting pathologic complete response (pCR) in early-stage triple negative ...Abuhadra, N et al, San Antonio Breast Cancer Symposium, Texas, USA, 12/8/2019
Research History
- Developing patient selection strategies for chemotherapy de-escalation in early-stage triple-negative breast cancer.2018 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
